CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells

Int J Mol Sci. 2017 Jun 14;18(6):1269. doi: 10.3390/ijms18061269.


Fanconi anemia (FA) is an inherited condition characterized by impaired DNA repair, physical anomalies, bone marrow failure, and increased incidence of malignancy. Gene editing holds great potential to precisely correct the underlying genetic cause such that gene expression remains under the endogenous control mechanisms. This has been accomplished to date only in transformed cells or their reprogrammed induced pluripotent stem cell counterparts; however, it has not yet been reported in primary patient cells. Here we show the ability to correct a mutation in Fanconi anemia D1 (FANCD1) primary patient fibroblasts. The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system was employed to target and correct a FANCD1 gene deletion. Homologous recombination using an oligonucleotide donor was achieved and a pure population of modified cells was obtained by using inhibitors of poly adenosine diphosphate-ribose polymerase (poly ADP-ribose polymerase). FANCD1 function was restored and we did not observe any promiscuous cutting of the CRISPR/Cas9 at off target sites. This consideration is crucial in the context of the pre-malignant FA phenotype. Altogether we show the ability to correct a patient mutation in primary FANCD1 cells in a precise manner. These proof of principle studies support expanded application of gene editing for FA.

Keywords: CRISPR/Cas9; Fanconi anemia; Fanconi anemia D1; fibroblasts; gene editing; poly adenosine diphosphate-ribose polymerase inhibitors.

MeSH terms

  • BRCA2 Protein / genetics*
  • BRCA2 Protein / metabolism
  • CRISPR-Cas Systems*
  • Cell Line
  • Cells, Cultured
  • Clustered Regularly Interspaced Short Palindromic Repeats
  • Fanconi Anemia / genetics*
  • Fanconi Anemia / metabolism
  • Fanconi Anemia / therapy*
  • Fibroblasts / metabolism
  • Gene Deletion
  • Gene Editing / methods*
  • Genetic Therapy / methods
  • Humans


  • BRCA2 Protein
  • BRCA2 protein, human

Supplementary concepts

  • Fanconi Anemia, Complementation Group D1